Professor Trevor Jones CBE FMed Sci
Zack Bellman
Positioned at the heart of the life sciences sector, the Cannabinoid Research & Development Group UK is a new research strategy group led by academics, researchers, clinicians, patients and industry.
The group will propel scientific research and development of pharmaceutical cannabinoid-related products in the UK.
Our ambition is to develop and implement a comprehensive strategy to transform the UK into the global leader in cannabinoid research and medicine development.
We will build a robust ecosystem by integrating universities, research institutions, investors, businesses, and the NHS – driving innovation and development, nurturing top talent and fostering advances in healthcare.
The CRDG represents an evolution of The Centre for MC, which formed in November 2019. Our archive includes all reports and papers published by the CDRG and the CMC.
Membership and general enquiries steve@crdg.uk.
Sign up for CRDG news and updates.